No photo of Alexis A Thompson

View Scopus Profile

Alexis A Thompson

  • 10352 Citations
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Grants

Active

ATHN Data Quality Counts Grant 11

Thompson, A. A.

American Thrombosis and Hemostasis Network

9/1/19 → 8/31/20

Project: Research project

BMN 270-301: A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Level

Thompson, A. A.

BioMarin Pharmaceutical Inc.

3/12/19 → 8/31/50

Project: Research project

Robert H. Lurie Comprehensive Cancer Center (Associate Directorship)

Chaudhury, S. & Thompson, A. A.

Northwestern University, National Cancer Institute

8/1/18 → 7/31/23

Project: Research project

Robert H. Lurie Comprehensive Cancer Center (Associate Directorship)

Chaudhury, S. & Thompson, A. A.

Northwestern University, National Cancer Institute

8/1/18 → 7/31/23

Project: Research project

LJ401-BT01 - A multi-center, randomized, open-label, parallel-group study with LJPC-401 for the treatment of myocardial iron overload in adult patients with transfusion-dependent beta thalassemia

Thompson, A. A.

La Jolla Pharmaceutical Company

5/25/18 → 5/24/21

Project: Research project

SEG101B2201: A phase 2, Multicenter, Open-Label Study to AssessAppropriate Dosing and to Evaluate Safety of Crizanlizumab, with or without Hydroxyurea/Hydroxycarbamide, in Sequential, Descending Age Groups of Pediatric Sickle

Thompson, A. A.

Novartis Pharmaceuticals Corporation

5/11/18 → 6/1/25

Project: Research project

ACE-536-B-THAL-002 - A Phase 2, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults with non transfusion dependent beta-Thalass

Thompson, A. A.

Celgene Corporation

3/1/18 → 2/28/23

Project: Research project

BMN 270-902: A Prospective Non-Interventional Study of Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A

Thompson, A. A.

BioMarin Pharmaceutical Inc.

2/28/18 → 2/27/21

Project: Research project

ETB115E2201: A phase II, open-label, non-controlled, intra-patient dose escalation study to characterize the pharmacokinetics after oral administration of eltrombopag in pediatric patients with refractory, relapsed or treatment

Thompson, A. A.

Novartis Pharmaceuticals Corporation

1/1/18 → 12/31/24

Project: Research project

Engaging Parents of Children with Sickle Cell Anemia and their Providers in Shared-Decision Making for Hydroxyurea

Thompson, A. A.

Cincinnati Children's Hospital Medical Center, Patient-Centered Outcomes Research Institute

12/1/17 → 11/30/20

Project: Research project

Engaging Parents of Children with Sickle Cell Anemia and their Providers in Shared-Decision Making for Hydroxyurea

Thompson, A. A.

Cincinnati Children's Hospital Medical Center, Patient-Centered Outcomes Research Institute

12/1/17 → 11/30/20

Project: Research project

Sickle Cell Disease Implementation Consortium (SCDIC)

Thompson, A. A.

Research Triangle Institute, National Heart, Lung, and Blood Institute

8/10/16 → 6/30/22

Project: Research project

Sickle Cell Disease Implementation Consortium (SCDIC)

Thompson, A. A.

Research Triangle Institute, National Heart, Lung, and Blood Institute

8/10/16 → 6/30/22

Project: Research project

Sickle Cell Disease Implementation Consortium (SCDIC)

Thompson, A. A.

Research Triangle Institute, National Heart, Lung, and Blood Institute

8/10/16 → 6/30/22

Project: Research project

Sickle Cell Disease Implementation Consortium (SCDIC)

Thompson, A. A.

Research Triangle Institute, National Heart, Lung, and Blood Institute

8/10/16 → 6/30/22

Project: Research project

ACE-536-B-THAL-001 - A Phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults who require regular red blood cell transfus

Thompson, A. A.

Celgene Corporation

6/1/16 → 5/31/21

Project: Research project

LTF-303: Long-term Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector

Thompson, A. A.

Bluebird Bio, Inc.

3/1/16 → 2/28/23

Project: Research project

Community Counts: Public Health Surveillance for Bleeding Disorders

Thompson, A. A.

Great Lakes Hemophilia Foundation, Centers for Disease Control

9/30/15 → 9/29/20

Project: Research project

Community Counts: Public Health Surveillance for Bleeding Disorders

Thompson, A. A.

Great Lakes Hemophilia Foundation, Centers for Disease Control

9/30/15 → 9/29/20

Project: Research project

Community Counts: Public Health Surveillance for Bleeding Disorders

Thompson, A. A.

Great Lakes Hemophilia Foundation, Centers for Disease Control

9/30/15 → 9/29/20

Project: Research project

Community Counts: Public Health Surveillance for Bleeding Disorders

Thompson, A. A.

Great Lakes Hemophilia Foundation, Centers for Disease Control

9/30/15 → 9/29/20

Project: Research project

Finished

IDPH Sickle Cell Follow Up (FY20)

Thompson, A. A.

Illinois Department of Public Health

7/1/19 → 6/30/20

Project: Research project

IDPH Sickle Cell Follow Up

Thompson, A. A.

Illinois Department of Public Health

7/1/18 → 6/30/19

Project: Research project

ATHN Data Quality Counts Grant 10.1

Thompson, A. A.

American Thrombosis and Hemostasis Network

7/1/18 → 8/31/19

Project: Research project

IDPH Sickle Cell Follow Up

Thompson, A. A.

Illinois Department of Public Health

7/1/17 → 6/30/18

Project: Research project